Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
6,200
Employees6,200
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
6,200
Employees6,200

MEDP Key Statistics

Market cap
13.35B
Market cap13.35B
Price-Earnings ratio
29.40
Price-Earnings ratio29.40
Dividend yield
Dividend yield
Average volume
249.90K
Average volume249.90K
High today
$479.30
High today$479.30
Low today
$466.41
Low today$466.41
Open price
$476.86
Open price$476.86
Volume
297.33K
Volume297.33K
52 Week high
$628.92
52 Week high$628.92
52 Week low
$294.07
52 Week low$294.07

Stock Snapshot

The current Medpace(MEDP) stock price is $471.22, with a market capitalization of 13.35B. The stock trades at a price-to-earnings (P/E) ratio of 29.40.

During the trading session on 2026-06-13, Medpace(MEDP) shares reached a daily high of $479.30 and a low of $466.41. At a current price of $471.22, the stock is +1.0% higher than the low and still -1.7% under the high.

Trading volume for Medpace(MEDP) stock has reached 297.33K, versus its average volume of 249.9K.

The stock's 52-week range extends from a low of $294.07 to a high of $628.92.

The stock's 52-week range extends from a low of $294.07 to a high of $628.92.

MEDP News

TipRanks 24h
Pritelivir Trial Update Highlights Medpace’s Role in Drug-Resistant HSV Market

Medpace Holdings Inc (MEDP) announced an update on their ongoing clinical study. Medpace Holdings, Inc. is helping run a Phase 3 trial that tests pritelivir in...

Analyst ratings

60%

of 15 ratings
Buy
33.3%
Hold
60%
Sell
6.7%

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.